Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI

Tempus, a genomic testing and data analysis company started by Eric Lefkosky, who previously founded Groupon, debuted on Nasdaq on Friday, rose about 15% on the opening  The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully-diluted valuation […]

© 2024 TechCrunch. All rights reserved. For personal use only.

ai analysis biotech & health data data analysis eric genomic health investor ipo lefkofksy nasdaq tech tempus testing the company trading